Stocks and Investing
Stocks and Investing
Wed, August 9, 2023
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
Justin Kim Reiterated (ALDX) at Buy and Held Target at $14 on, Aug 9th, 2023
Justin Kim of Oppenheimer, Reiterated "Aldeyra Therapeutics, Inc." (ALDX) at Buy and Held Target at $14 on, Aug 9th, 2023.
Justin has made no other calls on ALDX in the last 4 months.
There are 2 other peers that have a rating on ALDX. Out of the 2 peers that are also analyzing ALDX, 0 agree with Justin's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Justin
- Matthew Caufield of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Friday, June 30th, 2023
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $25 on, Thursday, June 1st, 2023
Contributing Sources